CONMED Past Earnings Performance
Past criteria checks 4/6
CONMED has been growing earnings at an average annual rate of 16.8%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 7.9% per year. CONMED's return on equity is 14.1%, and it has net margins of 10.2%.
Key information
16.8%
Earnings growth rate
15.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 7.9% |
| Return on equity | 14.1% |
| Net Margin | 10.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem
Nov 07
Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 02Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?
Oct 01Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price
Sep 12CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20
Aug 15CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price
Jul 17AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation
Jun 21There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding
Jun 01Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Apr 18Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%
Feb 15US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results
Feb 03Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?
Jan 08Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects
Dec 18CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt
Nov 30Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business
Oct 28Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?
Sep 22Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Aug 24Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly
Jul 28Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?
Jun 08These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively
May 17Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Apr 28Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Mar 10Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden
Feb 14CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M
Feb 02Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Jan 24ConMed: Still Fairly Priced, Turning More Constructive
Dec 09At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?
Nov 18Conmed withdraws FY22 guidance on software implementation-related disruption
Nov 15CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet
Oct 11Revenue & Expenses Breakdown
How CONMED makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,288 | 132 | 516 | 55 |
| 30 Jun 24 | 1,276 | 99 | 511 | 54 |
| 31 Mar 24 | 1,262 | 82 | 509 | 54 |
| 31 Dec 23 | 1,245 | 64 | 505 | 53 |
| 30 Sep 23 | 1,169 | 58 | 483 | 51 |
| 30 Jun 23 | 1,139 | 88 | 479 | 51 |
| 31 Mar 23 | 1,099 | -94 | 462 | 49 |
| 31 Dec 22 | 1,045 | -81 | 439 | 47 |
| 30 Sep 22 | 1,069 | -83 | 440 | 46 |
| 30 Jun 22 | 1,042 | -114 | 427 | 44 |
| 31 Mar 22 | 1,020 | 68 | 420 | 44 |
| 31 Dec 21 | 1,011 | 63 | 415 | 44 |
| 30 Sep 21 | 989 | 62 | 405 | 44 |
| 30 Jun 21 | 979 | 54 | 393 | 43 |
| 31 Mar 21 | 881 | 13 | 369 | 40 |
| 31 Dec 20 | 862 | 10 | 374 | 40 |
| 30 Sep 20 | 874 | 0 | 369 | 41 |
| 30 Jun 20 | 870 | 0 | 373 | 42 |
| 31 Mar 20 | 951 | 34 | 391 | 45 |
| 31 Dec 19 | 955 | 29 | 388 | 45 |
| 30 Sep 19 | 933 | 29 | 383 | 44 |
| 30 Jun 19 | 901 | 28 | 370 | 43 |
| 31 Mar 19 | 876 | 31 | 361 | 41 |
| 31 Dec 18 | 860 | 41 | 353 | 38 |
| 30 Sep 18 | 840 | 72 | 349 | 36 |
| 30 Jun 18 | 828 | 73 | 345 | 34 |
| 31 Mar 18 | 812 | 71 | 337 | 32 |
| 31 Dec 17 | 796 | 55 | 331 | 32 |
| 30 Sep 17 | 778 | 15 | 323 | 32 |
| 30 Jun 17 | 773 | 16 | 318 | 32 |
| 31 Mar 17 | 769 | 12 | 317 | 32 |
| 31 Dec 16 | 764 | 15 | 313 | 32 |
| 30 Sep 16 | 750 | 16 | 306 | 31 |
| 30 Jun 16 | 735 | 17 | 302 | 30 |
| 31 Mar 16 | 722 | 22 | 292 | 29 |
| 31 Dec 15 | 719 | 30 | 287 | 27 |
| 30 Sep 15 | 723 | 34 | 287 | 28 |
| 30 Jun 15 | 729 | 27 | 291 | 28 |
| 31 Mar 15 | 736 | 30 | 296 | 27 |
| 31 Dec 14 | 740 | 32 | 303 | 28 |
| 30 Sep 14 | 747 | 31 | 310 | 27 |
| 30 Jun 14 | 750 | 35 | 308 | 27 |
| 31 Mar 14 | 753 | 34 | 309 | 27 |
| 31 Dec 13 | 763 | 36 | 318 | 26 |
Quality Earnings: CNMD has a large one-off gain of $48.7M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: CNMD's current net profit margins (10.2%) are higher than last year (5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CNMD's earnings have grown by 16.8% per year over the past 5 years.
Accelerating Growth: CNMD's earnings growth over the past year (127.2%) exceeds its 5-year average (16.8% per year).
Earnings vs Industry: CNMD earnings growth over the past year (127.2%) exceeded the Medical Equipment industry 10.4%.
Return on Equity
High ROE: CNMD's Return on Equity (14.1%) is considered low.